company background image
1302 logo

LifeTech Scientific SEHK:1302 Stock Report

Last Price

HK$1.62

Market Cap

HK$7.5b

7D

-8.0%

1Y

-45.6%

Updated

18 Apr, 2024

Data

Company Financials +

LifeTech Scientific Corporation

SEHK:1302 Stock Report

Market Cap: HK$7.5b

1302 Stock Overview

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders.

1302 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance1/6
Financial Health6/6
Dividends0/6

LifeTech Scientific Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for LifeTech Scientific
Historical stock prices
Current Share PriceHK$1.62
52 Week HighHK$3.03
52 Week LowHK$1.59
Beta0.73
1 Month Change-7.95%
3 Month Change-17.77%
1 Year Change-45.64%
3 Year Change-61.79%
5 Year Change4.52%
Change since IPO548.00%

Recent News & Updates

What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You

Dec 25
What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You

Returns On Capital At LifeTech Scientific (HKG:1302) Have Stalled

Nov 28
Returns On Capital At LifeTech Scientific (HKG:1302) Have Stalled

At HK$2.37, Is LifeTech Scientific Corporation (HKG:1302) Worth Looking At Closely?

Nov 03
At HK$2.37, Is LifeTech Scientific Corporation (HKG:1302) Worth Looking At Closely?

Recent updates

What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You

Dec 25
What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You

Returns On Capital At LifeTech Scientific (HKG:1302) Have Stalled

Nov 28
Returns On Capital At LifeTech Scientific (HKG:1302) Have Stalled

At HK$2.37, Is LifeTech Scientific Corporation (HKG:1302) Worth Looking At Closely?

Nov 03
At HK$2.37, Is LifeTech Scientific Corporation (HKG:1302) Worth Looking At Closely?

Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)

Aug 17
Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)

Is There Now An Opportunity In LifeTech Scientific Corporation (HKG:1302)?

Jul 18
Is There Now An Opportunity In LifeTech Scientific Corporation (HKG:1302)?

Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)

May 05
Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)

Here's What To Make Of LifeTech Scientific's (HKG:1302) Decelerating Rates Of Return

Oct 14
Here's What To Make Of LifeTech Scientific's (HKG:1302) Decelerating Rates Of Return

There's Been No Shortage Of Growth Recently For LifeTech Scientific's (HKG:1302) Returns On Capital

Jul 15
There's Been No Shortage Of Growth Recently For LifeTech Scientific's (HKG:1302) Returns On Capital

Does LifeTech Scientific (HKG:1302) Deserve A Spot On Your Watchlist?

Jun 30
Does LifeTech Scientific (HKG:1302) Deserve A Spot On Your Watchlist?

A Look At The Fair Value Of LifeTech Scientific Corporation (HKG:1302)

Jun 15
A Look At The Fair Value Of LifeTech Scientific Corporation (HKG:1302)

Returns At LifeTech Scientific (HKG:1302) Are On The Way Up

Apr 03
Returns At LifeTech Scientific (HKG:1302) Are On The Way Up

Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock

Mar 15
Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock

Is LifeTech Scientific Corporation (HKG:1302) Potentially Undervalued?

Jan 22
Is LifeTech Scientific Corporation (HKG:1302) Potentially Undervalued?

Some Investors May Be Worried About LifeTech Scientific's (HKG:1302) Returns On Capital

Dec 19
Some Investors May Be Worried About LifeTech Scientific's (HKG:1302) Returns On Capital

Here's Why I Think LifeTech Scientific (HKG:1302) Might Deserve Your Attention Today

Dec 06
Here's Why I Think LifeTech Scientific (HKG:1302) Might Deserve Your Attention Today

Is LifeTech Scientific (HKG:1302) A Risky Investment?

Nov 20
Is LifeTech Scientific (HKG:1302) A Risky Investment?

An Intrinsic Calculation For LifeTech Scientific Corporation (HKG:1302) Suggests It's 34% Undervalued

Oct 12
An Intrinsic Calculation For LifeTech Scientific Corporation (HKG:1302) Suggests It's 34% Undervalued

The Returns On Capital At LifeTech Scientific (HKG:1302) Don't Inspire Confidence

Sep 13
The Returns On Capital At LifeTech Scientific (HKG:1302) Don't Inspire Confidence

Should You Be Adding LifeTech Scientific (HKG:1302) To Your Watchlist Today?

Aug 28
Should You Be Adding LifeTech Scientific (HKG:1302) To Your Watchlist Today?

What Is LifeTech Scientific Corporation's (HKG:1302) Share Price Doing?

Aug 13
What Is LifeTech Scientific Corporation's (HKG:1302) Share Price Doing?

LifeTech Scientific's (HKG:1302) Returns On Capital Not Reflecting Well On The Business

Jun 08
LifeTech Scientific's (HKG:1302) Returns On Capital Not Reflecting Well On The Business

Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock

May 26
Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock

Should You Investigate LifeTech Scientific Corporation (HKG:1302) At HK$4.14?

May 11
Should You Investigate LifeTech Scientific Corporation (HKG:1302) At HK$4.14?

LifeTech Scientific (HKG:1302) Could Easily Take On More Debt

Mar 31
LifeTech Scientific (HKG:1302) Could Easily Take On More Debt

Shareholders Are Thrilled That The LifeTech Scientific (HKG:1302) Share Price Increased 274%

Feb 21
Shareholders Are Thrilled That The LifeTech Scientific (HKG:1302) Share Price Increased 274%

Do Insiders Own Lots Of Shares In LifeTech Scientific Corporation (HKG:1302)?

Jan 26
Do Insiders Own Lots Of Shares In LifeTech Scientific Corporation (HKG:1302)?

Does LifeTech Scientific's (HKG:1302) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 13
Does LifeTech Scientific's (HKG:1302) Statutory Profit Adequately Reflect Its Underlying Profit?

Are Strong Financial Prospects The Force That Is Driving The Momentum In LifeTech Scientific Corporation's HKG:1302) Stock?

Nov 25
Are Strong Financial Prospects The Force That Is Driving The Momentum In LifeTech Scientific Corporation's HKG:1302) Stock?

Shareholder Returns

1302HK Medical EquipmentHK Market
7D-8.0%-2.3%-2.0%
1Y-45.6%-52.7%-14.3%

Return vs Industry: 1302 exceeded the Hong Kong Medical Equipment industry which returned -54% over the past year.

Return vs Market: 1302 underperformed the Hong Kong Market which returned -15% over the past year.

Price Volatility

Is 1302's price volatile compared to industry and market?
1302 volatility
1302 Average Weekly Movement5.6%
Medical Equipment Industry Average Movement7.4%
Market Average Movement7.5%
10% most volatile stocks in HK Market14.9%
10% least volatile stocks in HK Market3.8%

Stable Share Price: 1302's share price has been volatile over the past 3 months.

Volatility Over Time: 1302's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19991,448Yuehui Xiewww.lifetechmed.com

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, Heart, and Konara-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; delivery systems, such as Fustar steerable and SteerEase introducers; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; LawMax dilators; and SeQure snare systems, as well as pacemakers.

LifeTech Scientific Corporation Fundamentals Summary

How do LifeTech Scientific's earnings and revenue compare to its market cap?
1302 fundamental statistics
Market capHK$7.50b
Earnings (TTM)HK$284.82m
Revenue (TTM)HK$1.37b

26.3x

P/E Ratio

5.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1302 income statement (TTM)
RevenueCN¥1.27b
Cost of RevenueCN¥271.54m
Gross ProfitCN¥995.64m
Other ExpensesCN¥732.40m
EarningsCN¥263.24m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.057
Gross Margin78.57%
Net Profit Margin20.77%
Debt/Equity Ratio0%

How did 1302 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.